Patent application number | Description | Published |
20080208317 | Anchoring Device for Stent - Disclosed is a stent supporting device. The support device anchors a stent in a manner such that an anchoring stent is inserted into a branch blood vessel adjacent to an artery in which the stent is disposed, and the anchoring stent is connected to the stent. Accordingly, the support device is safe because it does not use subsidiary members such as screws, which can injure a blood vessel. Further, since the support device allows the stent to have a length corresponding to the size of a treatment site, that is, the stent does not need to be longer than the size of the treatment site, it is easy to install the stent. | 08-28-2008 |
20090087422 | Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same - The present invention relates to pharmaceutical compositions for treating diseases and conditions caused by ischemia. The pharmaceutical compositions contain a conjugate of a phospholipase (PL) polypeptide and a protein transduction domain (PTD). PLC-δ plays a major role in the regulation of cytosolic calcium levels. During myocardial ischemia, cytosolic calcium accumulation mediates pathogenic changes. According to the present invention, ischemic diseases or conditions leading to hypoxia in tissues, such as the heart and the brain, can be prevented or alleviated by administration of a PTD-PL conjugate. | 04-02-2009 |
20090269842 | TRANSMEMBRANE DELIVERY PEPTIDE AND BIO-MATERIAL COMPRISING THE SAME - The present invention relates to a transmembrane delivery peptide derived from human in which a target protein may be easily delivered into cells, and a recombinant vector comprising a nucleic acid coding the peptide. More specifically, the present invention relates to the transmembrane delivery peptide having an amino acid sequence described in SEQ ID No. 1 including 11 amino acids of specific sites in amino acid sequences of human G protein alpha 12, and a recombinant vector comprising a nucleic acid coding the same, a transformant prepared by introducing said recombinant vector, and the like. Since transmembrane delivery peptides of the present invention can be efficiently delivered into cells, they may be usefully used for the purposes of delivering various target materials, including proteins, nucleic acid, drugs and the like. | 10-29-2009 |
20100112562 | Mutation Implicated in Abnormality of Cardiac Sodium Channel Function - A novel mutation in the SCN5A gene is associated with loss of cardiac sodium channel function. Analysis of the novel mutation provides an early diagnosis of subjects with cardiac diseases or disorders caused by loss of cardiac sodium channel function, particularly Brugada syndrome. Diagnostic methods include analyzing the sequences of the SCN5A gene or protein of an individual to be tested and comparing them with the sequences of the native, nonvariant SCN5A gene or protein. Pre-symptomatic diagnosis of these syndromes will enable practitioners to treat these disorders using existing medical therapy, e.g., using sodium channel blockers or through electrical stimulation. | 05-06-2010 |
20110159479 | GENETIC POLYMORPHISMS IN THE CYTOCHROME P450 GENE WITH CLOPIDOGREL RESISTANCE - The present invention relates to a method for predicting the resistance of a human subject to clopidogrel, which comprises detecting the presence or absence of a A allele at position 636 of exon 4 in the CYP2C19 gene, wherein the presence of the A allele is indicative of a clopidogrel resistance. The present method may be very useful in predicting the resistance of a human subject to clopidogrel and contribute to more effective chemotherapy for patients having coronary artery disease and drug-eluting stent. | 06-30-2011 |
20120116500 | H-Side Branch Stent - Provided is an H-side branch stent including a first stent having a plurality of cells and a hollow cylindrical shape, at least one bridge having one end connected to a distal end of the first stent, and a second stent having a front end connected to the other end of the bridge, and having a plurality of cells and a hollow cylindrical shape. Accordingly, the H-side branch stent can prevent re-stenosis of the opening of the branch blood vessel since the stent can completely support an inner circumference of an opening of a branch blood vessel in a circumferential direction, and prevent blood flow disturbance because stents are not densely concentrated to a boundary between a main blood vessel and the branch blood vessel and some regions of the stent do not project into the main blood vessel. | 05-10-2012 |
20130109015 | Single Nucleotide Polymorphisms Associated with Left Ventricular Hypertrophy and Use Thereof | 05-02-2013 |
20130164847 | USE OF A PROTEIN TYROSINE KINASE INHIBITOR FOR INDUCING THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS INTO CARDIOGENIC CELLS - The present invention pertains to methods of using protein tyrosine kinase (PTK) inhibitors for inducing cell differentiation of mesenchymal stem cells into cardiac cells, and a pharmaceutical composition comprising the differentiated cardiac cells thereof to treat heart diseases. The transplantation of mesenchymal stem cells to the heart provides immunological and functional improvements, but does not provide electrical stability. However, the mesenchymal stem cells treated with PTK inhibitors are induced to be differentiated into cardiogenic cells to provide electrical stability as the electromechanical integration with host heart tissue is improved, and it is thus possible to effectively treat cardiac diseases such as cardiac infarction, cardiac insufficiency, arrhythmia and the like. | 06-27-2013 |
20130236969 | Use of Compounds for Inducing Differentiation of Mesenchymal Stem Cells to Chondrocytes - Use of a compound of Formula 1 for inducing differentiation of mesenchymal stem cells to chondrocytes, and a pharmaceutical composition for treating a cartilage disease, which includes chondrocytes in which differentiation from mesenchymal stem cells is induced by the compound of Formula 1, are provided. Differentiation of the mesenchymal stem cells treated with the compound of Formula 1 to chondrocytes is specifically induced, and thus the compound can be used to effectively treat a cartilage disease such as arthritis, cartilage damage, and a cartilage defect. | 09-12-2013 |
20140256034 | BIO-PIN - A bio-pin is provided. The bio-pin can be used for cell transfer and treatment, cell tracing, and targeting of specific tissues and cells using a peptide-based complex in which a cell-penetrating peptide or a cell-adhesive peptide is bound to one or both ends of a cell membrane protein, and used in a molecular imaging system, a medical appliance, and the like. | 09-11-2014 |
Patent application number | Description | Published |
20120258699 | METHOD FOR OPERATING PORTABLE TERMINAL TO REDUCE POWER DURING SUPPORT OF COMMUNICATION SERVICE AND PORTABLE TERMINAL SUPPORTING THE SAME - A method for operating a portable terminal so as to reduce power consumption during the support of a communication service and a portable terminal supporting the same is provided. The method includes activating a Radio Frequency (RF) communication unit, downloading a part of data of predetermined contents through the RF communication unit, buffering the downloaded part of the data in a buffer so as to output the buffered downloaded part of the data, and executing an idle time for terminating or reducing a power supply of the RF communication unit when the downloading of the part of the data of the predetermined contents is completed. | 10-11-2012 |
20130219177 | SECURE DATA PROCESSING DEVICE AND METHOD - A secure data processing device is provided. The device includes a main Operating System (OS), a plurality of main processes which are executed under control of the main OS and which are associated with each other, a secure OS which is simultaneously operated with the main OS, and at least one secure process which is executed under control of the secure OS and which corresponds to at least one of the plurality of main processes. If at least one of the plurality of main processes is in an abnormal operation state, an operation of the least one secure process is interrupted and initialized according to a request of the main OS. | 08-22-2013 |
20130219188 | APPARATUS AND METHOD FOR REPRODUCING CONTENTS IN ELECTRONIC DEVICE - An apparatus and a method for outputting contents where an Output Protection Level (OPL) has been set to an extension device in an electronic device are provided. The apparatus includes a secure processor for decrypting and decoding contents where a right to use the contents has been set using a secure Operating System (OS). When receiving an external output request for contents whose external output is not allowed, the secure processor stops generating of decoded data transmitted to an extension device. | 08-22-2013 |
20130219192 | CONTENTS SECURITY APPARATUS AND METHOD THEREOF - A contents security apparatus for preventing Standard Definition (SD) contents which are protected targets of a level which is relatively lower than that of High Definition (HD) contents from being processed through a trust zone of a processor thereof and a method thereof are provided. The contents security apparatus includes a processor for operating a first Operating System (OS) and for storing authentication information of at least one or more contents and a second OS for limiting access to the first OS, wherein the first OS decrypts and processes contents with a high security level and wherein the second OS decrypts and processes contents with a low security level. | 08-22-2013 |
20130219507 | METHOD AND APPARATUS FOR PROTECTING DIGITAL CONTENT USING DEVICE AUTHENTICATION - A user device may strengthen the protection level of a digital content by dividing the security and normal modes and performing an operation. In order to further strengthen the protection level of the digital content, the user device may determine whether the main operating system is hacked or not, and blocks the operation in the secure mode. Otherwise, the device authorization information indicating the device security level of the user device is authorized by the content service server, and the user device blocks the operation in the secure mode according to the result. | 08-22-2013 |
20140140256 | METHOD FOR OPERATING PORTABLE TERMINAL TO REDUCE POWER DURING SUPPORT OF COMMUNICATION SERVICE AND PORTABLE TERMINAL SUPPORTING THE SAME - A method for operating a portable terminal so as to reduce power consumption during the support of a communication service and a portable terminal supporting the same is provided. The method includes activating a Radio Frequency (RF) communication unit, downloading a part of data of predetermined contents through the RF communication unit, buffering the downloaded part of the data in a buffer so as to output the buffered downloaded part of the data, and executing an idle time for terminating or reducing a power supply of the RF communication unit when the downloading of the part of the data of the predetermined contents is completed. | 05-22-2014 |